﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Cision News</title><link>https://news.cision.com</link><description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description><pubDate>Tue, 09 Jun 2026 11:16:27 GMT</pubDate><image><title>Cision News</title><width>146</width><height>60</height><link>https://news.cision.com</link><url>https://news.cision.com/Content/img/news-logo.png</url></image><item><title>AGA acquires Hydrogas-Messers industrial gases operations in Sweden</title><link>http://news.cision.com/aga/r/aga-acquires-hydrogas-messer-s-industrial-gases-operations-in-sweden,c21204</link><guid isPermaLink="false">cision19356</guid><description><![CDATA[AGA ACQUIRES HYDROGAS-MESSER'S INDUSTRIAL GASES OPERATIONS IN SWEDEN AGA has acquired the Industrial Gases operations from Hydrogas-Messer AB, Sweden, a jointly owned company by Hydrogas and Messer-Griesheim. The Competition Authorities approved the acquisition on April 5, 2000. The agreement implies that the plant in Köping, for production and cylinder filling of gases, is taken over by AGA. The main part of the employees, 15 persons, will be offered employment at AGA. Hydrogas-Messer also has carbon dioxide operations in Sweden, which are not affected. For further information please]]></description><pubDate>Wed, 12 Apr 2000 08:40:37 GMT</pubDate></item><item><title>AGA's Annual General Meeting</title><link>http://news.cision.com/aga/r/aga-s-annual-general-meeting,c20410</link><guid isPermaLink="false">cision18568</guid><description><![CDATA[AGA'S ANNUAL GENERAL MEETING Dividend At the Annual General Meeting of AGA AB held on Thursday, March 30, 2000 a dividend for the 1999 fiscal year of Skr 3:00 per share (1998 3:00) was declared. The record date for the dividend is April 4, 2000. Dividends are expected to be paid through VPC on April 7, 2000. Board of Directors Lennart Selander was re-elected as ordinary Board Member. Jan Hammrlund, Lars Källsäter, Urban Murray and Leif Svensson were elected as ordinary Board Members. At the Board's constituting meeting following the Annual General Meeting, Lennart Selander was elected]]></description><pubDate>Thu, 30 Mar 2000 16:42:37 GMT</pubDate></item><item><title>Annual report 1999</title><link>http://news.cision.com/aga/r/annual-report-1999,c19381</link><guid isPermaLink="false">cision17549</guid><description><![CDATA[Annual report 1999 ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/2000/03/13/20000313BIT00820/bit0001.pdf Annual report]]></description><pubDate>Mon, 13 Mar 2000 16:16:30 GMT</pubDate></item><item><title>New Date for AGA's Annual General Meeting</title><link>http://news.cision.com/aga/r/new-date-for-aga-s-annual-general-meeting,c18897</link><guid isPermaLink="false">cision17065</guid><description><![CDATA[NEW DATE FOR AGA'S ANNUAL GENERAL MEETING The date for AGA's Annual General Meeting has been changed from March 27, 2000 to Thursday, March 30, 2000, at 3 p.m. (local time). Location: AGA Lidingö, Agavägen 1, Lidingö. Lidingö March 2, 2000 AGA Aktiebolag (publ) Corporate Communications ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/2000/03/02/20000302BIT00270/bit0001.doc http://www.bit.se/bitonline/2000/03/02/20000302BIT00270/bit0002.pdf]]></description><pubDate>Thu, 02 Mar 2000 09:46:52 GMT</pubDate></item><item><title>Annual General Meeting, March 27</title><link>http://news.cision.com/aga/r/annual-general-meeting--march-27,c18535</link><guid isPermaLink="false">cision16707</guid><description><![CDATA[AGA AKTIEBOLAG NOTICE OF ANNUAL GENERAL MEETING Shareholders of AGA Aktiebolag (publ) are hereby summoned to the Annual General Meeting on Monday March 27, 2000, at 10 a.m. (local time).Location: AGA Lidingö, Agavägen 1, Lidingö. Notification of Attendance, Etc. Shareholders intending to attend the Annual General Meeting must be recorded as shareholders in the Shareholders' Register issued by the Swedish Securities Register Center (Värdepapperscentralen VPC AB) as at March 17, 2000. Shareholders whose shares are registered in the names of trustees must temporarily register their shares in]]></description><pubDate>Fri, 25 Feb 2000 08:04:40 GMT</pubDate></item><item><title>Year-end report 1999</title><link>http://news.cision.com/aga/r/year-end-report-1999,c18444</link><guid isPermaLink="false">cision16618</guid><description><![CDATA[YEAR-END REPORT 1999 *Income before tax for 1999 amounted to SKr 1,460m (556). Earnings per share after full tax was SKr 4.61 (1.52). *Sales were largely unchanged at SKr 14,999m (15,088) after negative currency effects of approximately 2 percent. *Operating income, before items affecting comparability, amounted to SKr 1,747m (1,758). The corresponding operating margin was 11.6 percent (11.7). *Net cash flow from operations improved to SKr 521m (-14) after a dividend of SKr 730m (730). Capital expenditures for new plant amounted to SKr 1,450m (2,002) corresponding to 9.7 percent (13.3) of]]></description><pubDate>Thu, 24 Feb 2000 08:28:34 GMT</pubDate></item><item><title>Date for Year-End Report 1999</title><link>http://news.cision.com/aga/r/date-for-year-end-report-1999,c17947</link><guid isPermaLink="false">cision16123</guid><description><![CDATA[YEAR-END REPORT 1999 AGA's Year-end Report will be published on February 24, 2000. The Annual General Meeting will be held on March 20, 2000. Lidingö February 16, 2000 AGA Aktiebolag (publ) Corporate Communications ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/2000/02/16/20000216BIT00270/bit0001.doc http://www.bit.se/bitonline/2000/02/16/20000216BIT00270/bit0002.pdf]]></description><pubDate>Wed, 16 Feb 2000 09:00:32 GMT</pubDate></item><item><title>European Commission approves acquisition of AGA by Linde</title><link>http://news.cision.com/aga/r/european-commission-approves-acquisition-of-aga-by-linde,c17601</link><guid isPermaLink="false">cision15781</guid><description><![CDATA[PRESS RELEASE EUROPEAN COMMISSION APPROVES ACQUISITION OF AGA BY LINDE Linde AG's statement on the decision of the European Commission of February 9, 2000: "With today's decision the European Commission has given us a green light for a concentration of our forces on the integration of the Swedish company AGA. We have moved a decisive step closer to our strategic aim of continuously strengthening our position in the industrial gases business in Europe and beyond," commented Gerhard Full, chairman of the Linde executive board. The combination of AGA and Linde creates the fourth largest]]></description><pubDate>Wed, 09 Feb 2000 14:22:18 GMT</pubDate></item><item><title>AGA's INO Therapeutics receives US FDA approval</title><link>http://news.cision.com/aga/r/aga-s-ino-therapeutics-receives-us-fda-approval,c15938</link><guid isPermaLink="false">cision14130</guid><description><![CDATA[AGA's INO Therapeutics receives US FDA approval for treatment for critically ill newborns A new treatment that will help critically ill newborn infants breathe more effectively and reduce their need for an invasive surgical procedure has been approved by the US Food and Drug Administration. INO Therapeutics, Inc., a subsidiary of AGA, announced today that it has received approval for its new product, INOmax® (nitric oxide) for inhalation. INOmax®, the first and only pulmonary vasodilator, is indicated for the treatment of full-term and near-term newborn infants (more than 34 weeks gestation)]]></description><pubDate>Mon, 27 Dec 1999 13:04:36 GMT</pubDate></item><item><title>Aga Healthcare's INO Therapeutics receives US fda approvable notice</title><link>http://news.cision.com/aga/r/aga-healthcare-s-ino-therapeutics-receives-us-fda-approvable-notice,c14601</link><guid isPermaLink="false">cision12796</guid><description><![CDATA[AGA HEALTHCARE'S INO THERAPEUTICS RECEIVES US FDA APPROVABLE NOTICE FOR TREATMENT FOR CRITICALLY ILL NEWBORNS A new treatment for critically ill newborn infants to help them breathe more effectively and reduce their need for an invasive surgical procedure has received "approvable" status from the US Food and Drug Administration. INO Therapeutics, Inc., a subsidiary of the AGA Healthcare division of AGA AB, announced today that it has received notification from the FDA that its new TM product, INOmax (nitric oxide) for inhalation, is approvable. The company cannot promote or sell INOmax]]></description><pubDate>Tue, 23 Nov 1999 08:23:40 GMT</pubDate></item><item><title>Interim Report January - September 1999</title><link>http://news.cision.com/aga/r/interim-report-january---september-1999,c13546</link><guid isPermaLink="false">cision11743</guid><description><![CDATA[INTERIM REPORT JANUARY - SEPTEMBER 1999 (Unaudited) @Income before tax income increased by 15 percent to SKr 1,478m (1,288). Earnings per share after full tax rose to SKr 4.34 (3.68). @Sales amounted to SKr 11,157m (11,204). This level could be maintained despite a recession in South America and weak market growth in Europe. Healthcare's sales rose by 8 percent. @Operating income increased to SKr 1,446m (1,414) and the operating margin was 13.0 percent (12.6). @Net cash flow from operations improved to SKr 509m (-146). @Peter Sjöstrand is AGA's new chairman from October 26. @Linde now owns]]></description><pubDate>Wed, 27 Oct 1999 08:13:30 GMT</pubDate></item><item><title>Changes in AGAs Board of Directors</title><link>http://news.cision.com/aga/r/changes-in-agas-board-of-directors,c13327</link><guid isPermaLink="false">cision11526</guid><description><![CDATA[CHANGES IN AGAs BOARD OF DIRECTORS The Chairman of the Board of AGA AB, Sverker Martin-Löf, and the Board Members Tom Hedelius and Lennart Jeansson have decided to resign from their posts in AGA AB's Board of Directors. The background is that Linde AG, as announced earlier, has made their Offer for the acquisition and settlement of the AGA shares unconditional upon the approval by the relevant EU authorities. At present Linde owns more than 98 per cent of the number of shares and of the voting rights. At the ordinary Board Meeting on October 26 it is expected that the present Board Member]]></description><pubDate>Thu, 21 Oct 1999 14:12:48 GMT</pubDate></item><item><title>AGA's Extraordinary Shareholders' Meeting</title><link>http://news.cision.com/aga/r/aga-s-extraordinary-shareholders--meeting,c12417</link><guid isPermaLink="false">cision10619</guid><description><![CDATA[AGA's EXTRAORDINARY SHAREHOLDERS' MEETING AGA's Extraordinary Shareholders' Meeting, September 27, 1999, established the proposed change in the Articles of Association, - deletion of voting restrictions. Every shareholder with vote right can from now on vote for all the shares he or she represents. Lidingö September 27, 1999 AGA Aktiebolag (publ) Corporate Communications ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/09/27/19990927BIT00390/]]></description><pubDate>Mon, 27 Sep 1999 14:47:21 GMT</pubDate></item><item><title>Statement by the Board of Directors of AGA with Regard to Linde's Public Offer</title><link>http://news.cision.com/aga/r/statement-by-the-board-of-directors-of-aga-with-regard-to-linde-s-public-offer,c11877</link><guid isPermaLink="false">cision10079</guid><description><![CDATA[STATEMENT BY THE BOARD OF DIRECTORS OF AGA WITH REGARD TO LINDE'S PUBLIC OFFER Linde AG announced on August 16 their intention to make an offer for AGA AB. With regard to the announcement the Board of Directors of AGA has decided on the following statement: "Statement by the Board of Directors 1) The Board of Directors of AGA believes that a merger between AGA and Linde's business sector "Technical Gases" after the completed take-over of AGA by Linde is an industrially sound solution. The Board of Directors also believes that the price offered by Linde, SEK 141 for each share in AGA is]]></description><pubDate>Wed, 08 Sep 1999 14:16:46 GMT</pubDate></item><item><title>Offer to AGA's Shareholders</title><link>http://news.cision.com/aga/r/offer-to-aga-s-shareholders,c11205</link><guid isPermaLink="false">cision9409</guid><description><![CDATA[OFFER TO AGA's SHAREHOLDERS Linde AG has announced that it has acquired 62.5 % of the share capital and 62.8% of the voting rights in AGA for a price of SEK 141 per share, and intends to make a cash bid for all outstanding shares in the company for the same price. The detailed conditions for Linde's bid will be presented in a prospectus, which according to a preliminary timetable will be published in the second half of September. The Board of Directors will take a position on the bid when the detailed conditions are known and will put forward its recommendation on the bid in the prospectus.]]></description><pubDate>Tue, 17 Aug 1999 15:33:52 GMT</pubDate></item><item><title>Interim Report 1999</title><link>http://news.cision.com/aga/r/interim-report-1999,c11176</link><guid isPermaLink="false">cision9380</guid><description><![CDATA[INTERIM REPORT JANUARY - JUNE 1999 (Unaudited) *AGA reports income before tax for the first half of 1999 of SKr 1,181m (911). Earnings per share after full tax amounted to SKr 3.41 (2.57). *Sales amounted to SKr 7,483m (7,471). This level could be maintained in spite of weak economic development in the mature markets and a substantial devaluation in Brazil. Healthcare's sales rose by 9 percent. *Operating income was SKr 1,016m (962), which corresponds to an operating margin of 13.6 percent (12.9). Earnings include a SKr 70m capital gain from the sale of AGA's subsidiary in the U.K. as well]]></description><pubDate>Tue, 17 Aug 1999 11:14:43 GMT</pubDate></item><item><title>Press Release from Linde</title><link>http://news.cision.com/aga/r/press-release-from-linde,c11109</link><guid isPermaLink="false">cision9313</guid><description><![CDATA[Linde to make a public offer for AGA Linde AG, Germany, has announced its intention to make a cash offer for AGA AB, Sweden, of SEK 141 for each AGA Series-A and Series-B share. The offer values AGA at SEK 30.9 billion (approximately DM 6.9 billion, Euro 3.5 billion). Linde plans to preserve and develop the strong business and trademark of AGA. As of today, Linde owns shares representing 12.83 percent of AGA's capital and 6.96 percent of the votes and has entered into purchase agreements with Gas Vision AG, AB Industrivärden and funds connected with Svenska Handelsbanken Group, which,]]></description><pubDate>Mon, 16 Aug 1999 07:03:46 GMT</pubDate></item><item><title>New Headquarters Organization</title><link>http://news.cision.com/aga/r/new-headquarters-organization,c10154</link><guid isPermaLink="false">cision8367</guid><description><![CDATA[NEW HEADQUARTERS ORGANIZATION The AGA Headquarters will as of June 23, 1999 be adapted to the new operational organization that was introduced on June 8. The staffs and managers will be as follows: Marketing and development Martin Petersson, also responsible for Global Key Accounts Supply Stig Gebro Finance & Control Peter Fallenius Human Resources Ulf Johnsson Legal Urban Murray Investor Relations Arvid Liepe Corporate Communications Maris Sedlenieks Safety, Environment and Quality (SEQ) Lennart Fredriksson Each Staff Manager will report to the Group President. Before September 1 the]]></description><pubDate>Wed, 23 Jun 1999 08:16:12 GMT</pubDate></item><item><title>AGA's Test Results on Carbon Dioxide</title><link>http://news.cision.com/aga/r/aga-s-test-results-on-carbon-dioxide,c10113</link><guid isPermaLink="false">cision8327</guid><description><![CDATA[AGA'S TEST RESULTS ON CARBON DIOXIDE Last week the media reported that Coca Cola had to recall products in some European countries. One of the causes was said to be high concentration of sulfur compounds in carbon dioxide in the Coca Cola products. AGA supplies carbon dioxide to Coca Cola's bottling plant in Antwerp, Belgium. Careful analyses have proven that the carbon dioxide AGA supplied has fulfilled the given quality requirements. The usual regular analyses which are part of AGA's quality assurance system have been completed for the period in question. In addition, the carbon dioxide]]></description><pubDate>Tue, 22 Jun 1999 09:27:52 GMT</pubDate></item><item><title>AGA Files for Approval to Market INOmax in the United States</title><link>http://news.cision.com/aga/r/aga-files-for-approval-to-market-inomax-in-the-united-states,c10001</link><guid isPermaLink="false">cision8216</guid><description><![CDATA[AGA FILES FOR APPROVAL TO MARKET INOmax IN THE UNITED STATES Following its announcement of positive clinical trial results earlier this year, AGA has filed an application with the Food and Drug Administration (FDA) for approval to market INOmax in the United States. AGA is seeking approval to use inhaled nitric oxide, INOmax , for the treatment of hypoxemic respiratory failure in the term and the near-term newborn. Treatment INOmax is based on the discovery that in low concentrations, inhaled nictric oxide acts as a selective pulmonary vasodilator that dilates constricted blood vessels in]]></description><pubDate>Fri, 18 Jun 1999 08:38:48 GMT</pubDate></item><item><title>High Participation in AGA's Redemption Program</title><link>http://news.cision.com/aga/r/high-participation-in-aga-s-redemption-program,c9882</link><guid isPermaLink="false">cision8097</guid><description><![CDATA[HIGH PARTICIPATION IN AGA'S REDEMPTION PROGRAM The rate of participation in AGA's redemption program was 99.3%, which means that a total of 24.2 million shares have been submitted for redemption. In order to make sure that a total number of 24.3 million shares will be redeemed, the Board of Directors of AGA has decided, according to their authorization, to issue 179,581 B-shares. Svenska Handelsbanken has subscribed to these shares for a price of SEK 140 per share, equal to the redemption price. Svenska Handelsbanken will have the corresponding number of shares redeemed as part of the]]></description><pubDate>Mon, 14 Jun 1999 13:49:59 GMT</pubDate></item><item><title>New Organization</title><link>http://news.cision.com/aga/r/new-organization,c9747</link><guid isPermaLink="false">cision7965</guid><description><![CDATA[NEW ORGANIZATION To strengthen AGA's focus on profitability, a new organization will be introduced as of June 8. With this change it is expected that the on-going efficiency improvement program can be carried through earlier than planned. The industrial gas operations, consisting of the Business Areas Manufacturing and Process Industry, will be split into five geographical regions headed by a Regional Manager with responsibility for earnings in his region. A Global Key Account Manager has been appointed to strengthen the co-operation with AGA's global customers. Business Area Healthcare,]]></description><pubDate>Tue, 08 Jun 1999 15:55:39 GMT</pubDate></item><item><title>Change of President at AGA</title><link>http://news.cision.com/aga/r/change-of-president-at-aga,c9558</link><guid isPermaLink="false">cision7777</guid><description><![CDATA[CHANGE OF PRESIDENT AT AGA AGA's President, Lennart Selander, has agreed with the Board of Directors to retire from his position when he reaches the age of 60, in February 2000. The process of recruiting a successor has been initiated and is expected to be finalized during the autumn this year. The period immediately ahead will be utilized actively to strengthen the organization's focus on profitability while the Board's analysis and evaluation of AGA's future strategy towards increased concentration in terms of both products and markets will be intensified. The Manufacturing Industry and]]></description><pubDate>Tue, 01 Jun 1999 08:30:43 GMT</pubDate></item><item><title>Today AGA Grants One Million SEK to Medical Research</title><link>http://news.cision.com/aga/r/today-aga-grants-one-million-sek-to-medical-research,c9089</link><guid isPermaLink="false">cision7313</guid><description><![CDATA[TODAY AGA GRANTS ONE MILLION SEK TO MEDICAL RESEARCH In this year's presentation the AGA AB Medical Research Fund has awarded grants of SEK 10 million to research in the Nordic countries which is, or may become, significant for use of medical gases. AGA is thus one of the Nordic countries' foremost contributors to medical research. This year, the research grants will be shared by 15 Swedish, 4 Finnish and 2 Norwegian researchers, one of whom is Kristina Hambraeus Jonzon at the Karolinska Hospital in Stockholm. "My research is aimed at learning more about how nitrogen oxide, NO, affects the]]></description><pubDate>Tue, 11 May 1999 11:55:02 GMT</pubDate></item></channel></rss>